OraSure Technologies to Participate at the Sixth Annual JMP Securities Healthcare Conference
BETHLEHEM, Pa., Sep 21, 2011 (GlobeNewswire via COMTEX) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the Sixth Annual JMP Securities Healthcare Conference in New York City at approximately 10:00am Eastern Time (7:00am Pacific Time) on Tuesday, September 27, 2011. The conference will be simultaneously webcast over the Internet.
Interested investors can access the live audio webcast of the discussion by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Information link. A replay of the audio webcast will be available until October 4, 2011, on OraSure Technologies' web site. Alternatively, you can access the live webcast of the presentation via the following link: http://wsw.com/webcast/jmp14/osur/.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its innovative products include rapid tests for the detection of antibodies to HIV and HCV at the point of care and testing solutions for detecting various drugs of abuse. In addition, through its wholly-owned subsidiary, DNA Genotek Inc., the Company also is a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health.
For more information on OraSure Technologies, please visit www.orasure.com.
The OraSure Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6440
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: OraSure Technologies, Inc.
CONTACT: Ronald H. Spair
Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
